Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents.

作者: Heidrun Engler , Scott C Anderson , Todd R Machemer , Jennifer M Philopena , Robert J Connor

DOI: 10.1016/S0090-4295(98)00641-4

关键词: TransgeneUrotheliumGene deliveryGenetic enhancementPathologyAdenoviridaeUrinary bladderGeneMedicineEpitheliumCancer research

摘要: Abstract Objectives. Replication deficient adenoviral vectors (rAds) are used as gene delivery systems that can efficiently transduce a variety of tissues and may be appropriate to develop therapeutics for many urologic applications. However, the bladder epithelium has been shown highly resistant transgene expression after intracystic administration. A potential explanation this low transfer efficiency protective structure urothelium. Since barrier disrupted by organic solvents, we assessed whether ethanol co-administration enhance adenovirus-mediated expression. Methods. Normal tumor-bearing rats received single administration rAd encoding β-galactosidase (rAd-βgal) or p53 (rAd-p53). was administered in saline solution solutions with increasing concentrations ethanol. Transgene evaluated tissues. Results. dramatic increase urothelial achieved rAd-βgal 22% solution. enhanced normal urothelium superficial tumors. similarly enhanced. Conclusions. Co-administration local rAd-mediated neoplastic rodents. Improvement is progress toward enable therapy cancer other diseases.

参考文章(21)
L L Nielsen, D C Maneval, P53 tumor suppressor gene therapy for cancer. Cancer Gene Therapy. ,vol. 5, pp. 52- 63 ,(1998)
C. L. Parsons, J. D. Lilly, Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surgery gynecology & obstetrics. ,vol. 171, pp. 493- 496 ,(1990)
P Mathias, T Wickham, M Moore, G Nemerow, Multiple adenovirus serotypes use alpha v integrins for infection. Journal of Virology. ,vol. 68, pp. 6811- 6814 ,(1994) , 10.1128/JVI.68.10.6811-6814.1994
John Seigne, Yunli Zhou, Hong Ji Xu, William F. Benedict, Shi Xue Hu, Shi Xue Hu, Guang Shing Perng, Michael Mixon, Chunyan Zhang, Chunyan Zhang, Jian Li, Enhanced Tumor Suppressor Gene Therapy via Replication-deficient Adenovirus Vectors Expressing an N-Terminal Truncated Retinoblastoma Protein Cancer Research. ,vol. 56, pp. 2245- 2249 ,(1996)
Bernard G. Huyghe, Xiaodong Liu, Suganto Sutjipto, Barry J. Sugarman, Mark T. Horn, H. Michael Shepard, Carl J. Scandella, Paul Shabram, Purification of a Type 5 Recombinant Adenovirus Encoding Human p53 by Column Chromatography Human Gene Therapy. ,vol. 6, pp. 1403- 1416 ,(1995) , 10.1089/HUM.1995.6.11-1403
A Fabrega, M J Welsh, J Zabner, P Freimuth, A Puga, Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. Journal of Clinical Investigation. ,vol. 100, pp. 1144- 1149 ,(1997) , 10.1172/JCI119625
Ken N. Wills, Daniel C. Maneval, Patricia Menzel, Matthew P. Harris, Suganto Sutjipto, Mei-Ting Vaillancourt, Whei-Mei Huang, Duane E. Johnson, Scott C. Anderson, Shu Fen Wen, Robert Bookstein, H. Michael Shepard, Richard J. Gregory, Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Human Gene Therapy. ,vol. 5, pp. 1079- 1088 ,(1994) , 10.1089/HUM.1994.5.9-1079
Paul W. Shabram, Daniel D. Giroux, Ann M. Goudreau, Richard J. Gregory, Mark T. Horn, Bernard G. Huyghe, Xioadong Liu, Mary H. Nunnally, Barry J. Sugarman, Suganto Sutjipto, Analytical Anion-Exchange HPLC of Recombinant type-5 Adenoviral Particles Human Gene Therapy. ,vol. 8, pp. 453- 465 ,(1997) , 10.1089/HUM.1997.8.4-453
V.A. Chandiramani, T. Peterson, G.S. Duthie, C.J. Fowler, Urodynamic changes during therapeutic intravesical instillations of capsaicin BJUI. ,vol. 77, pp. 792- 797 ,(1996) , 10.1046/J.1464-410X.1996.09844.X
Tsuneo Masui, Yimin Dong, Shinji Yamamoto, Nobuyasu Takada, Hayao Nakanishi, Ken-ichi Inada, Shoji Fukushima, Masae Tatematsu, p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Cancer Letters. ,vol. 105, pp. 105- 112 ,(1996) , 10.1016/0304-3835(96)04268-1